0001567619-22-008630.txt : 20220418
0001567619-22-008630.hdr.sgml : 20220418
20220418190429
ACCESSION NUMBER: 0001567619-22-008630
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220414
FILED AS OF DATE: 20220418
DATE AS OF CHANGE: 20220418
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Love Douglas
CENTRAL INDEX KEY: 0001818520
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39402
FILM NUMBER: 22833065
MAIL ADDRESS:
STREET 1: C/O ANNEXON, INC.
STREET 2: 180 KIMBALL WAY, SUITE 200
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Annexon, Inc.
CENTRAL INDEX KEY: 0001528115
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 275414423
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1400 SIERRA POINT PARKWAY
STREET 2: BLDG C SUITE 200
CITY: BRISBANE
STATE: CA
ZIP: 94005
BUSINESS PHONE: (650)-822-5500
MAIL ADDRESS:
STREET 1: 1400 SIERRA POINT PARKWAY
STREET 2: BLDG C SUITE 200
CITY: BRISBANE
STATE: CA
ZIP: 94005
4
1
doc1.xml
FORM 4
X0306
4
2022-04-14
0
0001528115
Annexon, Inc.
ANNX
0001818520
Love Douglas
C/O ANNEXON, INC.
180 KIMBALL WAY, SUITE 200
SOUTH SAN FRANCISCO
CA
94080
1
1
0
0
President & CEO
Common Stock
2022-04-14
4
P
0
60000
2.4469
A
200942
D
The shares were purchased in multiple transactions at prices ranging from $2.41 to $2.50, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote.
Includes 160,942 shares held and 40,000 restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting.
/s/ Jennifer Lew, as Attorney-in-Fact for Douglas Love
2022-04-18